Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L6 pseudogene 21 (RPL6P21)
- Target
- RPL6P21
- Molecular classification
- Other (Pseudogene)
01
Overview
Ribosomal protein L6 pseudogene 21 (RPL6P21) is a processed human pseudogene found in the genome due to sequence homology with the active ribosomal protein L6 gene. While ribosomal protein L6 is a component of the large (60S) ribosomal subunit involved in protein synthesis, pseudogenes like RPL6P21 do not encode functional proteins, are not transcribed or translated under normal cellular conditions, and have no recognized biological or disease role[3][4][6]. RPL6P21 is cataloged in genetic databases but is not relevant as a molecular target for therapeutics, research, or disease mechanisms. If you are seeking information on a therapeutic target, the functional gene "Ribosomal protein L6" (RPL6) is distinct from RPL6P21, which is only a pseudogene. For the active protein, see "Ribosomal protein L6," which participates in ribosomal function and protein synthesis, and limited disease associations have been described for the functional gene[5][7].
- Other names
- RPL6_5_786RPL6P21
02
Mechanism of action
None (No drugs target this pseudogene. Mechanisms described for functional RPL6 do not apply here[7].)
03
Biological functions
Other (No known biological function; processed pseudogenes rarely retain functional roles in the cell. If any, they may participate in rare regulatory or non-coding RNA roles, but no evidence is available for RPL6P21 specifically[6].)
04
Disease associations
Other (No known disease associations. Disease links described for the functional gene RPL6 do not apply to this pseudogene[7].)
Beyond the preview
Go deeper on Ribosomal protein L6 pseudogene 21 (RPL6P21).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L6 pseudogene 21 (RPL6P21).